With the availability of new patient-applied treatments for genital and perianal warts, medical
providers, physician groups, and health systems are reassessing the role of physician …

Objective External genital warts are one of the fastest growing sexually transmitted diseases
in the United States today. Two forms of therapy are available: provider-administered and …

Objective: To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins
(Veregen) as first-line therapy against its principal comparator, imiquimod (Aldara), in the …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Data Sources: Studies were identified through a search of MEDLINE (1966-2000), the
Cochrane Library (issue 3, 2000), and PubMed (December 15, 2000). Reference lists of …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
43449661&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

A model was developed to estimate the cost-effectiveness of podophyllotoxin and imiquimod
for self-treatment of anogenital warts. The effectiveness endpoint was sustained clearance …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
43449661&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Objective: To compare the safety and effectiveness of 5% and 1% imiquimod cream with
vehicle cream in the treatment of external anogenital warts. Design: Randomized, double …

Objective To review published randomised controlled trials to assess the benefit and harm of
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …